Antimicrobial Susceptibility/Resistance of Streptococcus Pneumoniae

Emina Karcic1, Mufida Aljicevic2, Sabaheta Bektas3

  • 1Department of Pediatrics, Cantonal hospital, Zenica, Bosnia and Herzegovina.

Materia Socio-Medica
|August 4, 2015
PubMed
Abstract

Insights

Pneumococcal infections are a growing threat due to antibiotic resistance. This study found high resistance to erythromycin, clindamycin, and trimethoprim-sulfamethoxazole in Streptococcus pneumoniae, indicating these should be avoided in treatment.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Pneumococcal infections pose a significant global health burden.
  • Increasing antibiotic resistance in Streptococcus pneumoniae strains complicates treatment.
  • Antimicrobial resistance threatens the efficacy of current therapeutic strategies.

Purpose of the Study:

  • To investigate the antimicrobial susceptibility and resistance patterns of Streptococcus pneumoniae (S. pneumoniae).
  • To identify prevalent resistance mechanisms in clinical isolates.
  • To inform empirical treatment guidelines for pneumococcal infections.

Main Methods:

  • Collection of clinical samples including nasal, nasopharyngeal, eye, and ear swabs.
  • In vitro antimicrobial susceptibility testing using disk diffusion and E-test methods.
  • Evaluation of resistance against various antibiotic classes, including cell wall synthesis inhibitors, protein synthesis inhibitors, folate antagonists, and quinolones.

Main Results:

  • High resistance rates were observed for folate antagonists (47.78%) and cell wall synthesis inhibitors (39.17%).
  • Specific drug resistance included erythromycin (45%), clindamycin (45%), and oxacillin (73.89%).
  • Low resistance was noted for tetracycline (4.67%), penicillin-G (4.44%), and ciprofloxacin (1.11%).

Conclusions:

  • Streptococcus pneumoniae exhibits significant resistance to erythromycin, clindamycin, and trimethoprim-sulfamethoxazole.
  • These antibiotics should be used with caution or avoided in treating resistant pneumococcal infections.
  • Tetracycline, rifampicin, chloramphenicol, penicillin-G, and ciprofloxacin demonstrated lower resistance rates.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
113
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
41
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
47
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
2.0K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.9K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.2K